M. Oflas Et Al. , "The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer," 35'th Annual Congress of Nuclear Medicine , Barcelona, Spain, 2022
Oflas, M. Et Al. 2022. The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer. 35'th Annual Congress of Nuclear Medicine , (Barcelona, Spain).
Oflas, M., Has Şimşek, D., Işık, E. G., Cabıoğlu, N., İbiş, K., Aydıner, A., ... Mudun, A.(2022). The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer . 35'th Annual Congress of Nuclear Medicine, Barcelona, Spain
Oflas, Melis Et Al. "The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer," 35'th Annual Congress of Nuclear Medicine, Barcelona, Spain, 2022
Oflas, Melis Et Al. "The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer." 35'th Annual Congress of Nuclear Medicine , Barcelona, Spain, 2022
Oflas, M. Et Al. (2022) . "The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer." 35'th Annual Congress of Nuclear Medicine , Barcelona, Spain.
@conferencepaper{conferencepaper, author={Melis OFLAS Et Al. }, title={The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer}, congress name={35'th Annual Congress of Nuclear Medicine}, city={Barcelona}, country={Spain}, year={2022}}